infections

Breast milk establishes a ‘protective’ gut microbiota, promoting infant health

The findings of a recent study shed light on the role of complement proteins in breast milk and provide a mechanism through which breastfeeding may provide protection from certain bacterial…

A diverse gut microbiota prevents infection by blocking nutrient access

The findings of a recent study shed light on why gut microbiota diversity protects against infection. The results may also inform the design of pathogen-resistant microbial communities.

‘Hidden’ bacteria could explain recurrent urinary tract infections

The findings of a recent study indicate that effective treatments for recurrent UTIs may require the ability to penetrate human tissues.

Skin microbes may influence the outcome of leishmaniasis

The findings of a recent study may inform new therapies to modulate the skin microbiota in people with leishmaniasis.

The gut microbiota is linked to bloodstream infection in critically ill patients

The findings of a recent study link the gut microbiota and the microorganisms responsible for bloodstream infection in critically ill patients.

Study reveals the microbiota of people with genetic immune deficiency

A recent study analyzed microbial colonization in people with RAG deficiency to shed light on the effects of secondary immunodeficiencies.

Gianluca Ianiro: ‘Here’s why engraftment is a key determinant of success in FMT’

Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the key determinants of success of FMT in the treatment of C. Difficile infections and other conditions.

Microbial consortia may help fight intestinal infections

The findings of a recent study suggest that microbial consortia such as MET-2 may be effective strategies to keep intestinal pathogens and antibiotic-resistant organisms at bay.

How the human microbiota may help treat tough infections

Microbiota-based approaches could help researchers expand the therapeutic toolkit for fighting antibiotic resistance and treating tough infections.

Commercial manufacture of microbial therapeutics at Sacco Systems: from microliters to tons

Christophe Roca, Head of Pilot Department at Sacco System, talks about development and GMP production of Live Biotherapeutics for all applications.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.